Press Release Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001 10 hours ago
Press Release Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026 Aug 3
Press Release Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution Jul 29